Microbleeds (MBs) are thought to be clusters of hemosiderin-containing macrophages and are more commonly observed in hypertensive microangiopathy (lacunar infarct or intracerebral hemorrhage), cerebral amyloid angiopathy, or cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) but not exclusively in them.1 Although they are usually defined as the focal signal intensity loss of less than 5 or 10 mm, the conditions of gradient recalled-echo (GRE) varied among numerous previous studies about MBs (ie, TEs, were from 15 ms to 50 ms).2,3 We found that MBs are influenced in size and number by lengthening TE of GRE, as seen in the following case.
The GRE (TR, 700 ms; TE, 17 ms; flip angle, 20°) of an elderly hypertensive woman with right thalamic hemorrhage and multiple lacunar infarcts showed numerous MBs in the basal ganglia, thalami, pons, cerebellum, and cerebral white matter (Fig 1). The sizes and numbers of these MBs increased as the TE was lengthened (Fig 1). The numbers of MBs in this figure were 12 (TE, 10 ms), 14 (TE, 17 ms), and 20 (TE, 23 ms). The average diameter of MBs, which was 2.6 mm with a TE of 10 ms, became 3.8 (TE, 17 ms) and 4.5 mm (TE, 23 ms).
In general, the T2*-based signal intensity loss increases mainly by lengthening TE and decreasing the flip angle.4 To the best of our knowledge, no one has reported how the appearance of MBs changes with these parameters. As we have shown, MBs changed considerably in size and number as TE was prolonged. Therefore, the MR imaging parameter must be taken into account, especially when discussing the number or size of MBs.2,3 GRE with longer TE raises sensitivity of MBs, but the pathophysiological significance is to be clarified in the future.
The size and number of microbleeds increased by lengthening TE on GRE. Scale bar, 10 mm.
- Copyright © American Society of Neuroradiology
In this issue
Jump to section
Related Articles
Cited By...
- Cerebral Microbleeds on MR Imaging: Comparison between 1.5 and 7T
- MR Imaging Detection of Cerebral Microbleeds: Effect of Susceptibility-Weighted Imaging, Section Thickness, and Field Strength
- Patient-Specific Decision-Making for Warfarin Therapy in Nonvalvular Atrial Fibrillation: How Will Screening With Genetics and Imaging Help? * Supplemental Appendix
- Response to Letter by Vernooij et al